Research use only. Not for human or veterinary use.
Lab reports
Analysis reportAll specifications met

KLOW 80mg

Peptide Stock ref. PSV-2610-KLOW80-01

Lot
CP012607222280L
Manufactured
22 July 2026
Tested by
Axiom Analytics Laboratories
Analysed
10 October 2026
Purity99.68%HILIC-CAD + RP-HPLC 214 nm, per component
Content per vial83.47 mg104.3% of 80 mg label claim
IdentityConfirmedHILIC-ESI-MS (GHK-Cu) + LC-MS (ESI+)

Test results

TestSpecificationResultOutcome
Identity (LC-MS): GHK-CuWithin ±1 Da of 402.92 Da403.003 DaPass
Identity (LC-MS): BPC-157Within ±1 Da of 1419.556 Da1419.475 DaPass
Identity (LC-MS): TB-500Within ±1 Da of 4963.506 Da4963.415 DaPass
Identity (LC-MS): KPVWithin ±1 Da of 342.44 Da342.377 DaPass
Purity (RP-HPLC 214 nm): GHK-Cu≥ 99.25%99.9%Pass
Purity (RP-HPLC 214 nm): BPC-157≥ 99.25%99.35%Pass
Purity (RP-HPLC 214 nm): TB-500≥ 99.25%99.63%Pass
Purity (RP-HPLC 214 nm): KPV≥ 99.25%99.85%Pass
Content: GHK-Cu45–55 mg51.64 mgPass
Content: BPC-1579–11 mg10.79 mgPass
Content: TB-5009–11 mg10.55 mgPass
Content: KPV9–11 mg10.49 mgPass
Net peptide contentWithin ±10% of 80 mg83.47 mg (104.3% of claim)Pass
Sterility (rapid PCR)No microbial DNA detectedNot detectedPass

About this report

← All lab reports